CN110024039A - 处方用药信息合理性数据特征分析*** - Google Patents
处方用药信息合理性数据特征分析*** Download PDFInfo
- Publication number
- CN110024039A CN110024039A CN201680087137.2A CN201680087137A CN110024039A CN 110024039 A CN110024039 A CN 110024039A CN 201680087137 A CN201680087137 A CN 201680087137A CN 110024039 A CN110024039 A CN 110024039A
- Authority
- CN
- China
- Prior art keywords
- prescription
- information
- data
- drug
- prescriptions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004458 analytical method Methods 0.000 title claims abstract description 41
- 239000003814 drug Substances 0.000 claims abstract description 111
- 229940079593 drug Drugs 0.000 claims abstract description 104
- 238000011156 evaluation Methods 0.000 claims description 45
- 238000003745 diagnosis Methods 0.000 claims description 7
- 201000010099 disease Diseases 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- 238000007689 inspection Methods 0.000 claims description 4
- 208000024891 symptom Diseases 0.000 claims description 4
- 206010061623 Adverse drug reaction Diseases 0.000 claims description 3
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 claims description 3
- 238000002483 medication Methods 0.000 claims description 3
- 238000012360 testing method Methods 0.000 claims description 3
- 230000036541 health Effects 0.000 claims description 2
- 230000003993 interaction Effects 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 235000015097 nutrients Nutrition 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims description 2
- 239000013589 supplement Substances 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims 1
- 238000001647 drug administration Methods 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000012545 processing Methods 0.000 abstract description 5
- 230000007246 mechanism Effects 0.000 abstract description 4
- 238000000034 method Methods 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 238000012550 audit Methods 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 238000007405 data analysis Methods 0.000 description 3
- 230000003907 kidney function Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 238000007630 basic procedure Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000010365 information processing Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Information and communication technology [ICT] specially adapted for implementation of business processes of specific business sectors, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Social work or social welfare, e.g. community support activities or counselling services
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Business, Economics & Management (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Tourism & Hospitality (AREA)
- Data Mining & Analysis (AREA)
- Human Resources & Organizations (AREA)
- Databases & Information Systems (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- Strategic Management (AREA)
- Biomedical Technology (AREA)
- General Business, Economics & Management (AREA)
- Marketing (AREA)
- Pathology (AREA)
- Economics (AREA)
- Child & Adolescent Psychology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
本发明涉及一种处方合理性数据特征分析***，该***能够通过对用户处方样本的数据的处理，在处方用药关系数据库和处方用药风险数据库的基础上，全面分析本区域或本医疗机构处方数据的合理性特征，对处方中药品使用与法定用药标准存在差异的各种情况，以及其发生的原因、分布、风险等进行识别，帮助用户（尤其是医疗保险管理机构）能够客观、实际、均衡的建立处方管控数据标准，有效开展处方合理性的智能审核。
Description
PCT国内申请，说明书已公开。
Claims (9)
- PCT国内申请，权利要求书已公开。
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2016/089837 WO2018010105A1 (zh) | 2016-07-12 | 2016-07-12 | 处方用药信息合理性数据特征分析*** |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110024039A true CN110024039A (zh) | 2019-07-16 |
Family
ID=60952295
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201680087137.2A Pending CN110024039A (zh) | 2016-07-12 | 2016-07-12 | 处方用药信息合理性数据特征分析*** |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN110024039A (zh) |
| WO (1) | WO2018010105A1 (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110767277A (zh) * | 2019-09-09 | 2020-02-07 | 卫宁健康科技集团股份有限公司 | 区域电子药历的管理方法及*** |
| CN111028936A (zh) * | 2019-12-14 | 2020-04-17 | 曹庆恒 | 一种医疗检查及检验合理合规性分析的方法、***和设备 |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108447536B (zh) * | 2018-03-19 | 2022-01-25 | 杭州逸曜信息技术有限公司 | 基于疾病特征和疾病程度信息的用药信息处理方法 |
| CN109636623A (zh) * | 2018-10-19 | 2019-04-16 | 平安医疗健康管理股份有限公司 | 医疗数据异常检测方法、装置、设备及存储介质 |
| CN109508869B (zh) * | 2018-10-23 | 2023-09-22 | 平安医疗健康管理股份有限公司 | 一种基于数据处理的风险检测方法和装置 |
| CN109523395B (zh) * | 2018-10-24 | 2023-08-18 | 平安医疗健康管理股份有限公司 | 基于异常操作识别的医疗监管方法、装置、终端及介质 |
| CN110911014B (zh) * | 2019-05-29 | 2023-04-25 | 中国人民解放军联勤保障部队第九二〇医院 | 一种门诊重复用药查询分析方法及*** |
| CN112070260A (zh) * | 2019-06-11 | 2020-12-11 | 复旦大学附属妇产科医院 | 基于妇产科用药规则的优化方法、审核***、设备和介质 |
| CN112712864B (zh) * | 2021-01-07 | 2024-03-29 | 深圳坐标软件集团有限公司 | 一种可依据业务及政策配置规则的临床用药辅助方法及终端 |
| CN113724829A (zh) * | 2021-08-30 | 2021-11-30 | 康键信息技术（深圳）有限公司 | 处方审核方法和装置、电子设备、存储介质 |
| CN114066368A (zh) * | 2021-11-23 | 2022-02-18 | 宜阳县中医院 | 一种中医院药房药材存放及自动供给*** |
| CN114822877A (zh) * | 2022-06-21 | 2022-07-29 | 阿里健康科技(杭州)有限公司 | 信息显示方法、问诊装置 |
| CN117690597B (zh) * | 2023-11-29 | 2024-06-18 | 重庆爱永星辰标准医药服务有限公司 | 一种基于互联网的生物医药信息聚类分析方法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102737165A (zh) * | 2012-06-07 | 2012-10-17 | 北京太元通软件科技有限公司 | 临床用药决策支持*** |
| CN103854136A (zh) * | 2014-03-13 | 2014-06-11 | 华中科技大学同济医学院附属协和医院 | 带有用药安全监控干预功能的医院用药管理*** |
| CN104463456A (zh) * | 2014-12-03 | 2015-03-25 | 长沙中科院文化创意与科技产业研究院 | 一种面向患者的医疗处方审核***及其方法 |
| CN104487972A (zh) * | 2014-09-29 | 2015-04-01 | 曹庆恒 | 一种多维度用药信息处理方法、***和设备 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104008464A (zh) * | 2014-06-17 | 2014-08-27 | 北京大学第一医院 | 医院药师技能测评*** |
-
2016
- 2016-07-12 WO PCT/CN2016/089837 patent/WO2018010105A1/zh active Application Filing
- 2016-07-12 CN CN201680087137.2A patent/CN110024039A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102737165A (zh) * | 2012-06-07 | 2012-10-17 | 北京太元通软件科技有限公司 | 临床用药决策支持*** |
| CN103854136A (zh) * | 2014-03-13 | 2014-06-11 | 华中科技大学同济医学院附属协和医院 | 带有用药安全监控干预功能的医院用药管理*** |
| CN104487972A (zh) * | 2014-09-29 | 2015-04-01 | 曹庆恒 | 一种多维度用药信息处理方法、***和设备 |
| CN104463456A (zh) * | 2014-12-03 | 2015-03-25 | 长沙中科院文化创意与科技产业研究院 | 一种面向患者的医疗处方审核***及其方法 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110767277A (zh) * | 2019-09-09 | 2020-02-07 | 卫宁健康科技集团股份有限公司 | 区域电子药历的管理方法及*** |
| CN111028936A (zh) * | 2019-12-14 | 2020-04-17 | 曹庆恒 | 一种医疗检查及检验合理合规性分析的方法、***和设备 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018010105A1 (zh) | 2018-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110024039A (zh) | 处方用药信息合理性数据特征分析*** | |
| Naseralallah et al. | Impact of pharmacist interventions on medication errors in hospitalized pediatric patients: a systematic review and meta-analysis | |
| CN110337695A (zh) | 基于业务单元数据特征的处方管控数据标准管理*** | |
| Yu et al. | Multiplicity of medication safety terms, definitions and functional meanings: when is enough enough? | |
| Falconer et al. | Defining and classifying terminology for medication harm: a call for consensus | |
| Bonnabry et al. | Use of a systematic risk analysis method to improve safety in the production of paediatric parenteral nutrition solutions | |
| CN110867237A (zh) | 一种对合理及合规用药***的规则库进行管理的方法、***和设备 | |
| Kennedy et al. | Should oral contraceptive pills be available without a prescription? A systematic review of over-the-counter and pharmacy access availability | |
| Adams et al. | Haloperidol versus placebo for schizophrenia | |
| Adelufosi et al. | Pyridoxal 5 phosphate for neuroleptic‐induced tardive dyskinesia | |
| Benkirane et al. | Assessment of a new instrument for detecting preventable adverse drug reactions | |
| Al‐Bachari et al. | Gabapentin add‐on for drug‐resistant partial epilepsy | |
| Fong et al. | Integrating natural language processing expertise with patient safety event review committees to improve the analysis of medication events | |
| Hua et al. | Structure formats of randomised controlled trial abstracts: a cross-sectional analysis of their current usage and association with methodology reporting | |
| Bao et al. | A novel clinical pharmacy management system in improving the rational drug use in department of general surgery | |
| Oh et al. | Simultaneous comparison of efficacy and tolerability of second-generation antipsychotics in schizophrenia: mixed-treatment comparison analysis based on head-to-head trial data | |
| Shawahna | Scoping and bibliometric analysis of promoters of therapeutic inertia in hypertension. | |
| WO2016122664A1 (en) | Method and system for prescribing and determining risk associated with medications | |
| Sengupta et al. | Data quality assessment and multi-organizational reporting: tools to enhance network knowledge | |
| Yang et al. | Pharmacist‐led, prescription intervention system‐assisted feedback to reduce prescribing errors: A retrospective study | |
| Delnevo et al. | Modeling patients' online medical conversations: a granger causality approach | |
| Crump et al. | Preterm birth and risk of medically treated hypothyroidism in young adulthood | |
| Nasuhara et al. | Physicians’ responses to computerized drug interaction alerts with password overrides | |
| Mayo-Wilson et al. | Restoring invisible and abandoned trials of gabapentin for neuropathic pain: a clinical and methodological investigation | |
| CN110911014B (zh) | 一种门诊重复用药查询分析方法及*** |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |